TIS 0.00% 0.0¢ tissue therapies limited

Cleanest way would be an issue to sophs for around $5-6m - keeps...

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Cleanest way would be an issue to sophs for around $5-6m - keeps us going till launch underway and sp higher. Then a decision on timing of FDA approval project and whether company can fund out of cash flow or more equity - or blend of both.

    DYOR
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.